key: cord-0811792-rdbgz2lw
authors: Yang, Shujuan; Pan, Xiongfeng; Zeng, Peibin; Jia, Peng
title: Spatial technologies to strengthen traditional testing for SARS-CoV-2
date: 2021-03-14
journal: Trends Microbiol
DOI: 10.1016/j.tim.2021.03.003
sha: 42b6060b4ad5cf65ee5238c1ea2223890cd03747
doc_id: 811792
cord_uid: rdbgz2lw

Advanced spatial and digital technologies may help us take fuller advantage of limited testing resources to monitor the infection status of a large population in a cost-effective manner. Moreover, they may provide additional evidence to supplement results of nucleic acid testing for SARS-CoV-2, to decrease false negative and false positive rates.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused coronavirus disease 2019 (COVID-19) that, rapidly spreading to more than 200 countries worldwide, has been defined as a pandemic in March 2020. Reverse transcriptase-polymerase chain reaction (RT-PCR), the most widely used nucleic acid testing (NAT) for SARS-CoV-2, has routinely been used to confirm the diagnosis of COVID-19 since the beginning of this pandemic. However, according to the existing research, the sensitivity of RT-PCR could substantially vary and be as low as 33% [1, 2] . Although other traditional test methods, including computed tomography (CT) scanning and antibody tests, could be combined with NAT to improve the rate of diagnosis of SARS-COV-2 infection, all of them may suffer from limited testing capacity and materials (e.g., assays) during public health emergencies, especially at the early stages of the epidemic outbreak [3, 4] . Advanced spatial and digital technologies may help us take fuller advantage of limited testing resources to monitor the infection status of a large population in a cost-effective manner. Moreover, they may provide additional evidence to supplement traditional test results for decreasing false negative and false positive rates (Figure 1 ).

Spatial epidemiological approaches in a Geographic Information Systems (GIS) environment, such as spatial clustering analysis, have been used to examine geographic distribution patterns of disease cases, which enables efficient and cost-effective use of healthcare resources [5] . For example, local clustering analysis, one type of spatial clustering analysis, may detect and target limited resources at significant spatial clusters of COVID-19 cases in the region of interest, which would substantially reduce the cost of NAT and overcome the insufficiency of testing resources at the early stage of the epidemic. Moreover, space-time clustering analysis (e.g., Kulldorff's scan statistical method) may further reveal spatiotemporal clusters of cases. The results of these analyses could target limited testing resources to the regions of greatest need. However, the rapid spread of COVID-19 and the demand for identifying asymptomatic COVID-19 patients have challenged the paradigm of spatial epidemiology [6] .

Providing additional evidence to supplement NAT results J o u r n a l P r e -p r o o f Journal Pre-proof Spatial lifecourse epidemiology (i.e., modern spatial epidemiology in the era of big data) utilizes advanced spatial, location-based, and artificial intelligence technologies to investigate long-term effects of dynamic environmental, behavioral, psychosocial, and biological exposures on human health, as well as the underlying mechanisms [7] . It has been recognized as a promising transdisciplinary paradigm to tackle the dynamic and multidimensional nature of emerging epidemics [8, 9] . Real-time location data from mobile service providers and/or smartphone-based apps, the two important data sources of human movement in spatial lifecourse epidemiology, have been playing a critical role in curbing COVID-19 epidemic. For example, combining individual movement patterns of COVID-19 infected cases and other citizens could determine one's contact history and hence the level of risk for COVID-19 infection; this method may be made more precise with the assistance of Bluetooth, which could better identify valid contact between individuals (e.g., the distance between two persons is less than 1.5 m) [10] . The data of contact history have been incorporated into smartphone-based apps and used at checkpoints in some countries, to determine whether one has traveled to high-risk cities in the past two weeks.

Spatial and digital technologies may play a larger role in the detection of COVID-19 infection, if data-sharing mechanisms and infrastructures (e.g., data-sharing protocols, inter-system interface, confidentiality protection mechanisms) were properly set up ahead. For example, a COVID-19 risk score, representing the totality of one's spatiotemporal exposures to COVID-19 infected/suspected cases and infectious environments, may be calculated on the basis of his/her fine-scale contact history. One such score may serve as an important evidence of the infection status at COVID-19 test centers [11] , and help prevent false positives from being isolated and false negatives from going unnoticed. That is to say, one who is tested positive for SARS-CoV-2 and has recent exposure to COVID-19 risk is more likely to be true positive, and quarantine should be considered. On the contrary, one tested positive is likely to be false positive, if lacking recent exposure to COVID-19 risk. A short quarantine period may be needed in some situations, but another NAT with a different sample type (e.g., nasopharyngeal swabs, oral pharyngeal swabs, or throat swabs) should follow. Similarly, one who is test negative for SARS-CoV-2 and has no recent exposure to COVID-19 risk is more likely to be true negative. On the opposite direction, one who is tested negative but has recent exposure to COVID-19 risk would require health professionals to select additional test method(s) to confirm the infection status. The test method selection should consider the exact time of one's exposure to COVID-19 risk and to what extent (i.e., the duration and intensity of the exposure), which enables estimating one's possible onset date (and time) of symptoms. That is to say, if the test date is within the estimated incubation period, the negative SARS-CoV-2 test result may imply an early-stage infector; in this case, a short quarantine period may be needed and another NAT test should be followed. If the test date is past the estimated incubation period, the negative SARS-CoV-2 test result may imply an asymptomatic patient during the recovery period, in which case, a CT test may be needed to detect lesions or other subtle changes (e.g., lung parenchymal changes).

The aforementioned COVID-19 risk score may also enable dividing the region of interest into communities with different levels of risk, which could substantially reduce the cost of large-scale interventions, for example, blanket testing, by providing precise guidance on the selection of test locations and methods. Communities without any historical trace of confirmed and suspected cases could be excluded from blanket testing. A sample pooling strategy, previously used for community monitoring of infectious diseases by mixing a pre-selected number of samples together in a batch, may be considered in low-risk J o u r n a l P r e -p r o o f Journal Pre-proof communities where individuals do not have exposure history but some present COVID-19-like syndrome [12] . Individual testing is needed only if a given pool exhibits a positive result, so that the waste of testing resources could be substantially reduced in those communities due to a low chance of COVID-19 infection. Moreover, the number of samples pooled in such strategies is usually determined by the local prevalence of COVID-19 on the basis of confirmed cases [13] , which could be better estimated based on spatiotemporal exposures to COVID-19 risk of all the people in the community. In high-risk communities, it is still possible to differentiate low-risk and high-risk individuals on the basis of their contact history. NAT may be optimal to low-risk individuals, while CT may be more efficient for high-risk individuals due to the uncertain sensitivity of NAT.

As COVID-19 transmission has extended from animal-human and human-human to environment-human, some other advanced spatial technologies, such as remote sensing (i.e., earth observation), may also help select sites of greatest need for detection and interventions [14] . They are especially useful when healthcare resources are limited during emergency events, and/or when an epidemic has become a pandemic at the global scale. Remote sensing features a simultaneous data acquisition capacity over a large region, and also has a short revisit time (i.e., the time elapsed between two continuous observations of the same location by a satellite) for the majority of Earth's landmasses. These unique advantages make it possible to monitor the environmental conditions supporting SARS-CoV-2 survival and COVID-19 transmission in real time, once the potential environmental determinants of the increasing cases are identified. For example, temporal increases in COVID-19 cases might be associated with short-term variations in ambient air pollution. Remote sensing possesses the capacity of acquiring air pollutant concentration over a large region within a short time period (e.g., covering the whole of China within two hours and twice per day), which makes it possible to conduct a dynamic classification of regions with different levels of risk, and hence prioritize high-risk regions for interventions (e.g., conducting SARS-CoV-2 tests) [15] .

Spatial and digital technologies in spatial lifecourse epidemiology would leverage fine-scale individual contact histories from multiple sources (e.g., population/syndromic surveillance systems, crowdsourced data, social networks) to provide additional objective evidence for determining the necessity of receiving traditional tests, and for assisting medical staff in interpreting test results of traditional methods including NAT. In the future, one's fine-scale contact histories are expected to be imported, and/or integrated with traditional test results, in artificial intelligence-based, portable decision-making systems, to improve the cost-effective use of testing resources and the diagnostic accuracy of COVID-19 patients. However, protecting individual confidentiality should be paramount when integrating spatial and digital methods with traditional test methods. Some frameworks and protocols with different levels of confidentiality protection have been developed during the COVID-19 pandemic, including Decentralized Privacy-Preserving Proximity Tracing and Pan-European Privacy-Preserving Proximity Tracing, which aim to minimize the risk for disclosing individuals' confidentiality of infected patients while notifying people of their potential contact with those patients. All in all, these hybrid strategies, on the premise of fully protecting individual privacy, would significantly advance our capacity of curbing epidemics as soon as possible, and better prepare us for entering a new era of high-impact and high-frequency epidemics [9] . 

Detection of SARS-CoV-2 in fecal samples with different pretreatment methods and PCR kits

The sensitivity and specificity of chest CT in the diagnosis of COVID-19

Monitoring COVID-19 where capacity for testing is limited: use of a three-step analysis based on test positivity ratio

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review

Understanding the Epidemic Course in Order to Improve Epidemic Forecasting

Time to spatialise epidemiology in China

Spatial lifecourse epidemiology

Spatial Lifecourse Epidemiology and Infectious Disease Research

Are we ready for a new era of high-impact and high-frequency epidemics?

Digital technologies in the public-health response to COVID-19

China needs a national intelligent syndromic surveillance system

Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2

Pool size selection when testing for SARS-CoV-2

We thank the International Institute of Spatial Lifecourse Epidemiology (ISLE) for research support.